Stock
LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock LFMDP
Overview
LFMDP market data
Price History
LFMDP price chart
Valuation & Profitability
- P/E (TTM)
- 829.68 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.32 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.94 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.9% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 0.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.56 – $7.32 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $166.8M · P/B 7.09 · P/S 0.82.
Company News
8-K filing — LifeMD, Inc. (LFMDP)SEC EDGAR · Aug 5, 2026, 8:10 PM
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) InjectionGlobenewswire Inc · Jun 22, 2026, 12:15 PM